Author:
den Broeder A. A.,Creemers M. C. W.,van Gestel A. M.,van Riel P. L. C. M.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference19 articles.
1. Fries JF, Williams CA, Ramey D, Bloch DA. The relative toxicity of disease‐modifying antirheumatic drugs. Arthritis Rheum1993;36:297–306.
2. Moreland LW, Heck LW Jr, Koopman WJ. Biologic agents for treating rheumatoid arthritis. Concepts and progress. Arthritis Rheum1997;40:397–409.
3. Furst DE, Keystone E, Maini RN, Smolen JS. Recapitulation of the round‐table discussion—assessing the role of anti‐tumour necrosis factor therapy in the treatment of rheumatoid arthritis. Rheumatology1999;38(Suppl. 2):50–3.
4. Elliott MJ, Maini RN, Feldmann M et al. Randomised double‐blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet1994;344:1105–10.
5. Moreland LW, Baumgartner SW, Schiff MH et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)‐Fc fusion protein. N Engl J Med1997;337:141–7.
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献